PIVOT – SOLMIC COLLABORATION AND LICENSE AGREEMENTSolmic Collaboration and License Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
This COLLABORATION AND LICENSE AGREEMENT is made this 23rd day of September 2017 (hereinafter the “Effective Date”), by and between PIVOT PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o 1275 West 6th Street, Suite 300, Vancouver, BC V6C 1A6 (hereinafter “PIVOT”) and SolMic GmbH, a corporation organized under the laws of Germany with an address Merowingerplatz 1a, 40225 Dusseldorf, Germany, (hereinafter “SOLMIC”). PIVOT and SOLMIC herein may be referred to individually as “Party” or together as “Parties.”
BINDING LETTER OF INTENT – TECHNOLOGY LICENSING AGREEMENTTechnology Licensing Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
FIELD Pivot wishes to acquire worldwide rights for the development and commercialization of Thrudermic Nano Technology for all cannabinoids.
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Pivot Pharmaceuticals Inc., a company incorporated under the laws of British Columbia and having its head office located at 1275 West 6th Avenue, Suite 300, Vancouver, BC Canada V6H 1A6
